Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference


NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a Pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in proprietary digitally connected devices, announced that Michael Demurjian, CEO & Chairman, will participate in a panel discussion at the American Urological Association (AUA) Innovation Nexus Conference in Las Vegas, Nevada, taking place on April 25, 2025.

Originally posted here:
Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference

Related Posts